Literature DB >> 14691292

TNF-independent development of transient anemia of chronic disease in a mouse model of protracted septic peritonitis.

Thomas Schubert1, Bernd Echtenacher, Ferdinand Hofstädter, Daniela N Männel.   

Abstract

TNF is considered one of the inflammatory cytokines and contributes mainly to the generation of anemia of chronic disease (ACD). In nude mice TNF has been reported to impair iron metabolism and erythropoiesis, leading to anemia with a low serum iron and preserved iron stores. In this work, we established a murine model for ACD based on sublethal cecal ligation and puncture (CLP) with ensuing protracted peritonitis. Starting on Day 3 after CLP, a severe protracted depression of erythropoiesis in the bone marrow was noted. Two weeks after CLP, we observed a moderate normochromic anemia, low serum iron concentration, and preserved iron stores consistent with transient ACD. To determine whether TNF contributes to the development of ACD in vivo, we neutralized TNF after CLP shortly before and during the phase of most severe bone marrow depression to prevent anemia. Additionally, we studied TNF-deficient mice undergoing CLP. Two weeks after CLP, we determined red blood count, hemoglobin concentration, hematocrit, serum iron concentration, and iron stores in spleens of wild-type mice, TNF-deficient mice, and mice after neutralization of TNF. Neutralization of TNF after CLP could not prevent mice from contracting anemia. Accordingly, TNF-deficient mice developed anemia to the same extent as wild-type mice. Serum iron concentration was lowered and iron stores were overloaded in both TNF-deficient and wild-type mice after CLP. Our results clearly demonstrate that TNF is not a mediator of ACD in our model with transient anemia induced by protracted septic peritonitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691292     DOI: 10.1097/01.lab.0000101693.12149.2c

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Association between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis.

Authors:  Flaviane Alves de Pinho; Célia Maria Vieira Vendrame; Bruna Leal Lima Maciel; Lucilene Dos Santos Silva; Samantha Ive Miyashiro; Selma Maria Bezerra Jerônimo; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

Review 2.  Impaired hematopoietic progenitor cells in trauma hemorrhagic shock.

Authors:  Manoj Kumar; Sanjeev Bhoi
Journal:  J Clin Orthop Trauma       Date:  2016-06-22

3.  Persistent inflammation and anemia among critically ill septic patients.

Authors:  Tyler J Loftus; Juan C Mira; Julie A Stortz; Tezcan Ozrazgat-Baslanti; Gabriella L Ghita; Zhongkai Wang; Babette A Brumback; Ricardo F Ungaro; Azra Bihorac; Christiaan Leeuwenburgh; Frederick A Moore; Lyle L Moldawer; Scott C Brakenridge; Philip A Efron; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2019-02       Impact factor: 3.313

Review 4.  Animal models of anemia of inflammation.

Authors:  Seth Rivera; Tomas Ganz
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

Review 5.  Animal Models of Normal and Disturbed Iron and Copper Metabolism.

Authors:  Xiaoyu Wang; Michael D Garrick; James F Collins
Journal:  J Nutr       Date:  2019-12-01       Impact factor: 4.798

6.  Cytokines, granulocyte-monocyte colony stimulating factor, interleukin-3 and erythropoietin: Can be a therapeutic option for the stimulation of hematopoietic progenitor cells in trauma-hemorrhagic shock?

Authors:  Manoj Kumar; Sanjeev Bhoi
Journal:  Indian J Crit Care Med       Date:  2016-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.